A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients

NCT07573332 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

AQP4+ NMOSD

Interventions

BIOLOGICAL: CC-97540 (BMS-986353)
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Tocilizumab

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]